About Coolsculpting

Coolsculpting is a device that was created to allow non-surgeons to be able to offer patients a way of body contouring. The device and its technology is based on sound science. It had been found that fat cells or lip rich cells were more susceptible to cryo or freezing energy. This meant that if you could lower the temperature in an area of the body the fat cells should freeze and die but not the other cells like muscle, bone, skin and blood vessels. Over a few weeks to months it was thought that the body would absorb and remove the frozen fat.  However the promise of surgical results without surgery has led to a rapid rise in use and many unanticipated consequences. When comparing coolsculpting to liposuction coolsculpting is more costly, painful, and most importantly less predictable. The creators of Coolsculpting even list the following common immediate side effects in their fine print: Common Immediate Side Effects: Redness, firmness, pinching sensation, minor swelling, tenderness, bruising, stinging, tingling, numbness, skin sensitivity, mild to moderate pain and muscle cramping.

Why do patients from around the world seek Neinstein Plastic Surgery after Coolsculpting?

All patients receiving Coolsculpting will have redness, swelling, and soreness but rarely the fat may actually grow. The fat from coolsculpting does not just grow like regular fat but it becomes large, hard, and creates a very abnormal appearance. Scientific community has called this fat growing after Coolsculpting deformity “Paradoxical Adipose Hyperplasia After Cryolipolysis” This term means random, sudden, fat growth after freezing. We do not know why this happens or whom it will happen in. The emotional burden placed on patients who have this is immense. It can cause intense emotional distress and even shame in patients who sought to improve themselves when they are left scarred and deformed. Dr. Neinstein has become an expert in fixing, treating fat growth from coolsculpting and helping patients regain their confidence.